Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Therapeutic Innovation & Regulatory Science|May 17, 2023
Digital Tools-Regulatory Considerations for Application in Clinical TrialsLian Gelis, Isabelle Stoeckert, Hans-Peter Podhaisky
Journal of Dermatological Science|March 28, 2002
Is the photoprotective effect of vitamin E based on its antioxidative capacity?Hans-Peter Podhaisky, Wolfgang Wohlrab
Therapeutic Innovation & Regulatory Science|July 13, 2026
How Digital Health Technologies have been Used to Support Regulatory Drug ApprovalAgathe Thierry, Antoine Manson, Hans-Peter Podhaisky
Acta Dermato-Venereologica|November 15, 2002
Relevance of reactive oxygen species in the induction of 8-oxo-2'-deoxyguanosine in HaCaT keratinocytesStephan Riemschneider, Hans-Peter Podhaisky, Thomas Klapperstück, et al.
Pharmacological Research|March 9, 2002
Evidence for a role of nitric oxide in the mediation of antiproliferative UVA effects in keratinocytesHans-Peter Podhaisky, Thomas Klapperstück, Stephan Riemschneider, et al.
Therapeutic Innovation & Regulatory Science|January 28, 2025
Impact of Rule 11 on the European Medical Software Landscape: Analysis of EUDAMED and Further Databases Three Years After MDR ImplementationArndt A Schmitz, Miriam Font-Nieves, Toumani Doucouré, et al.
The Journal of Pharmacy and Pharmacology|November 11, 2003
Examinations of the antioxidative properties of the topically administered drug bufexamac reveal new insights into its mechanism of actionHagen Trommer, Manuela Plätzer, Klaus Raith, et al.
Pageof 3